Oncology
News
Drugs
Xagena Medicine
Xagena.net
LHRH agonists show promise in early breast cancer
Women with ductal carcinoma in situ overestimate breast cancer risks
HPV-positive head and neck cancer patients tend to survive longer than HPV-negative patients
Bevacizumab: VEGF neutralization can damage brain vessels
Breast cancer patients with diabetes: Metformin increases pathologic complete response rates
Erbitux in combination with Docetaxel and Cisplatin as induction therapy in patients treated for locally advanced head and neck cancer
Cancer: Vitamin C injections slow growth in mouse models
Tykerb blocks the growth of breast cancer cells that spread to the brain in a mouse model
Camptosar plus Avastin in the treatment of glioblastoma multiforme
Serious health problems associated with blocking angiogenesis signaling from inside cell
Broccoli and related vegetables: DIM can boost immune system
Avastin shows encouraging results in phase II study in patients with glioblastoma multiforme
Arterial thromboembolic events: chemotherapy with Bevacizumab increases risk
Glaucoma: fluctuating eye pressure linked to visual field deterioration
Advanced breast cancer: Neuvenge, an active cellular immunotherapy
Androgen-independent prostate cancer: Provenge improves survival
Breast cancer: molecular markers predict risk years before the tumor develops
Hepatocellular carcinoma: Nexavar significantly prolongs overall survival
Lung tumor ablation: reports of deaths associated with the use of radiofrequency ablation devices
Cancer patients treated with bisphosphonates: management of osteonecrosis of the jaw
Lapatinib in brain metastases associated with breast cancer
Lapatinib in combination with Paclitaxel as first-line treatment for patients with metastatic or relapsed advanced breast cancer
MAGE-A3 ASCI: clinical activity of a novel cancer immunotherapeutic in patients with non-small cell lung cancer
Advanced renal cell carcinoma: Temsirolimus improves overall survival
Primary gastrointestinal stromal tumor: Imatinib decreases cancer recurrence
Men with breast cancer face high risk of second cancer
Acetylsalicylic acid saves lives of cancer patients suffering myocardial infarction
Osteosarcoma: no benefit to increasing dose intensity of chemotherapy
Periodontal disease associated with increased risk of pancreatic cancer
Gemcitabine appears to delay cancer recurrence following surgery for pancreatic cancer
Next Pages [
1
]
2
3
4
5
6
7
8
9
10
»
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions
